Portfolio includes treatments for Alzheimer's disease, ADHD, Parkinson's disease, vision loss and severe burns Amarantus to receive Emerald Organics Preferred Stock for the exclusive worldwide license Emerald Organic CEO Ian Parker: "Emerald Organic will bring breakthrough therapies - and hope - to burn victims and those suffering from Alzheimer's and… Read More..

Active Ingredient in SGX301 for the Treatment of Cutaneous T-Cell Lymphoma PRINCETON, N.J., Oct. 24, 2019 /PRNewswire/ -- Soligenix, Inc. (SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the United States (US) Patent… Read More..

Proceeds from Non-Dilutive Financing to be Used to Achieve Near-Term Milestones CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has entered into a term… Read More..